Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Honorio Silva

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
American Journal of Therapeutics|June 19, 2009
Cardiovascular risk awareness, treatment, and control in urban Latin AmericaHonorio Silva, Rafael Hernandez-Hernandez, Raul Vinueza, et al.
Frontiers in Pharmacology|April 9, 2020
Evolution of the Development of Core Competencies in Pharmaceutical Medicine and Their Potential Use in Education and TrainingPeter D Stonier, Honorio Silva, Alan Boyd, et al.
Journal of Hypertension|October 8, 2009
Hypertension in seven Latin American cities: the Cardiovascular Risk Factor Multiple Evaluation in Latin America (CARMELA) studyRafael Hernández-Hernández, Honorio Silva, Manuel Velasco, et al.
Atherosclerosis|April 17, 2018
Corrigendum to "HDL-C, triglycerides and carotid IMT: A meta-analysis of 21,000 patients with automated edge detection IMT measurement" [Atherosclerosis 232 (2014) 65-71]Pierre-Jean Touboul, Julien Labreuche, Eric Bruckert, et al.
Atherosclerosis|January 10, 2014
HDL-C, triglycerides and carotid IMT: a meta-analysis of 21,000 patients with automated edge detection IMT measurementPierre-Jean Touboul, Julien Labreuche, Eric Bruckert, et al.
Cerebrovascular Diseases (Basel, Switzerland)|October 29, 2010
Common carotid artery intima-media thickness: the Cardiovascular Risk Factor Multiple Evaluation in Latin America (CARMELA) study resultsPierre-Jean Touboul, Eric Vicaut, Julien Labreuche, et al.
Frontiers in Pharmacology|May 1, 2015
Education and training for medicines development, regulation, and clinical research in emerging countriesSandor Kerpel-Fronius, Bernd Rosenkranz, Elizabeth Allen, et al.
Frontiers in Medicine|January 11, 2021
Development and Use of Gene Therapy Orphan Drugs-Ethical Needs for a Broader Cooperation Between the Pharmaceutical Industry and SocietySandor Kerpel-Fronius, Varvara Baroutsou, Sander Becker, et al.
The American Journal of Medicine|January 12, 2008
CARMELA: assessment of cardiovascular risk in seven Latin American citiesHerman Schargrodsky, Rafael Hernández-Hernández, Beatriz Marcet Champagne, et al.
Frontiers in Pharmacology|September 21, 2018
The Shared Ethical Responsibility of Medically and Non-medically Qualified Experts in Human Drug Development TeamsSandor Kerpel-Fronius, Sander Becker, Jane Barrett, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
American Journal of Therapeutics|June 19, 2009
Cardiovascular risk awareness, treatment, and control in urban Latin AmericaHonorio Silva, Rafael Hernandez-Hernandez, Raul Vinueza, et al.
Frontiers in Pharmacology|April 9, 2020
Evolution of the Development of Core Competencies in Pharmaceutical Medicine and Their Potential Use in Education and TrainingPeter D Stonier, Honorio Silva, Alan Boyd, et al.
Journal of Hypertension|October 8, 2009
Hypertension in seven Latin American cities: the Cardiovascular Risk Factor Multiple Evaluation in Latin America (CARMELA) studyRafael Hernández-Hernández, Honorio Silva, Manuel Velasco, et al.
Atherosclerosis|April 17, 2018
Corrigendum to "HDL-C, triglycerides and carotid IMT: A meta-analysis of 21,000 patients with automated edge detection IMT measurement" [Atherosclerosis 232 (2014) 65-71]Pierre-Jean Touboul, Julien Labreuche, Eric Bruckert, et al.
Atherosclerosis|January 10, 2014
HDL-C, triglycerides and carotid IMT: a meta-analysis of 21,000 patients with automated edge detection IMT measurementPierre-Jean Touboul, Julien Labreuche, Eric Bruckert, et al.
Cerebrovascular Diseases (Basel, Switzerland)|October 29, 2010
Common carotid artery intima-media thickness: the Cardiovascular Risk Factor Multiple Evaluation in Latin America (CARMELA) study resultsPierre-Jean Touboul, Eric Vicaut, Julien Labreuche, et al.
Frontiers in Pharmacology|May 1, 2015
Education and training for medicines development, regulation, and clinical research in emerging countriesSandor Kerpel-Fronius, Bernd Rosenkranz, Elizabeth Allen, et al.
Frontiers in Medicine|January 11, 2021
Development and Use of Gene Therapy Orphan Drugs-Ethical Needs for a Broader Cooperation Between the Pharmaceutical Industry and SocietySandor Kerpel-Fronius, Varvara Baroutsou, Sander Becker, et al.
The American Journal of Medicine|January 12, 2008
CARMELA: assessment of cardiovascular risk in seven Latin American citiesHerman Schargrodsky, Rafael Hernández-Hernández, Beatriz Marcet Champagne, et al.
Frontiers in Pharmacology|September 21, 2018
The Shared Ethical Responsibility of Medically and Non-medically Qualified Experts in Human Drug Development TeamsSandor Kerpel-Fronius, Sander Becker, Jane Barrett, et al.
Pageof 3